Hand Exoskeleton Training Study
Launched by MEDSTAR HEALTH RESEARCH INSTITUTE · Jan 15, 2025
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
The Hand Exoskeleton Training Study is researching a special device called HandMATE, which aims to help people who have had a stroke improve their hand movement and strength. The study will look at how well this device works for rehabilitation and whether stroke survivors find it helpful and easy to use. Participants will use the HandMATE both in a clinic and at home, and they will also take part in assessments to measure their hand function.
To join the study, participants need to be at least 21 years old and have had a stroke more than six months ago, confirmed by a medical scan. They should have some ability to move their hand but may have difficulty opening it fully. It's important to note that individuals with certain conditions, like severe sensory loss or ongoing therapy that conflicts with the study, won't be eligible. Participants can expect to learn more about their hand function while using the HandMATE device and contributing to important research that could help many stroke survivors.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age of 21 or older
- • diagnosis of stroke more than 6 months prior confirmed from MRI or CT
- • voluntary hand activity (score of 1 or more, finger extension item, Fugl-Meyer Test)
- • adequate cognitive status
- • Impaired ability to open affected hand
- Exclusion Criteria:
- • hemispatial neglect
- • severe sensory loss (2 or more on the sensory item, NIH Stroke Scale/Score)
- • receiving or planning to receive antispasticity medications during enrollment into the study
- • less than full passive range of motion in finger joints
- • receiving physical or occupational therapy outside of study protocols
- • have excessive pain in any joint of the affected extremity that could limit ability to cooperate with the protocols
About Medstar Health Research Institute
MedStar Health Research Institute (MHRI) is a leading clinical research organization affiliated with MedStar Health, dedicated to advancing medical knowledge and improving patient care through innovative research initiatives. With a robust portfolio of clinical trials across various therapeutic areas, MHRI collaborates with healthcare professionals, academic institutions, and industry partners to facilitate the development of new treatments and interventions. The institute is committed to maintaining the highest standards of ethical conduct and scientific rigor while fostering a culture of inquiry that enhances the health and well-being of the communities it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Washington, District Of Columbia, United States
Patients applied
Trial Officials
Pete Lum, PhD
Principal Investigator
MedStar RI
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported